Clopidogrel pharmacogenetics: Beyond candidate genes and genome-wide association studies.

Abstract excerpt

While it is well established that genetic variation is a significant contributor to interindividual variability in clopidogrel efficacy, candidate gene and genome-wide approaches have failed to reproducibly identify genetic determinants of antiplatelet response, apart from variants in CYP2C19, prompting the need for more innovative study designs. Herein, we highlight the potential benefit of exome sequencing of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Clopidogrel
• Share to Cytochrome P-450 CYP2C19
• Share to Exome